Skip to content
DataLookout
Menu

GTIHNONCT07540611

Gonadotropin Therapy in Idiopathic Hypogonadal Non-Obstructive

StatusNot Yet Recruiting
PhaseNot applicable
Primary completion (estimated)

At risk: Primary completion moved 10 months later.

Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 2 versions: 2 with changes below. See every version on ClinicalTrials.gov ↗

  1. Notable Primary completion pushed from Jan 16, 2027 to Nov 16, 2027 Show 5 more changesShow less
    • Start date: Jul 17, 2026 to Jan 17, 2027
    • Eligibility criteria shortened, about 28 words
    • Study completion pushed from Jul 17, 2027 to Jun 17, 2028
    • Secondary endpoints: details revised at 2 of 10 entries
    • Publications: details revised at 3 of 3 entries
  2. Study First Submitted
  • Notable: the plan changed

Endpoints

Primary

Success or Sperm Availability
Timeframe: from randomization through Week 16 via ejaculate or micro-TESE

Secondary (10)

Micro-TESE Sperm Retrieval Rate (SSR)
Need for Micro-TESE Surgery
Safety / Harms
ICSI Fertilization Rate
Blastulation Rate
Show 5 moreShow less
Blastocyst Quality
Top-Quality Blastocyst Rate
Clinical Pregnancy Rate
Miscarriage Rate
Live Birth

Arms and interventions

hCG + FSH therapyExperimental
Standard of CareActive comparator

Other: No intervention, hCG + FSH therapy

Sites

8 sites in 1 country